How to buy Vir Biotechnology stock (VIR)

Vir Biotechnology is a biotechnology business based in the US. Vir Biotechnology shares (VIR) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $7.37 – a decrease of 1.07% over the previous week. Vir Biotechnology employs 587 staff and has a trailing 12-month revenue of around $78.6 million.

Our top picks for where to buy Vir Biotechnology stock

Buy Vir Biotechnology stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Vir Biotechnology stock price (NASDAQ: VIR)

Use our graph to track the performance of VIR stocks over time.

Vir Biotechnology shares at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$7.37
52-week range	$6.56 - $13.09
50-day moving average more info button	$8.02
200-day moving average more info button	$8.94
Wall St. target price	$29.50
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-3.93

Is it a good time to buy Vir Biotechnology stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Vir Biotechnology price performance over time

Historical closes compared with the close of $7.155 from 2024-12-18

1 week (2024-12-13)	-3.96%
1 month (2024-11-20)	6.16%
3 months (2024-09-20)	-7.80%
6 months (2024-06-20)	-20.06%

1 year (2023-12-20)	-25.55%
2 years (2022-12-20)	-71.96%
3 years (2021-12-20)	51.16
5 years (2019-12-20)	12.27

Vir Biotechnology financials

Revenue TTM	$78.6 million
Gross profit TTM	$1 billion
Return on assets TTM	-19.41%
Return on equity TTM	-36.58%
Profit margin	0%
Book value	$9.08
Market Capitalization more info button	$985.4 million

TTM: trailing 12 months

Vir Biotechnology share dividends

We're not expecting Vir Biotechnology to pay a dividend over the next 12 months.

Vir Biotechnology share price volatility

Over the last 12 months, Vir Biotechnology's shares have ranged in value from as little as $6.56 up to $13.09. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Vir Biotechnology's is 0.457. This would suggest that Vir Biotechnology's shares are less volatile than average (for this exchange).

Vir Biotechnology overview

Vir Biotechnology, Inc. , an immunology company, develops therapeutic products to treat and prevent serious infectious diseases. Its clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc. ; license agreements with MedImmune, LLC; collaboration with WuXi Biologics (Hong Kong) Limited and Glaxo Wellcome UK Ltd. ; and a collaborative research agreement with GlaxoSmithKline Biologicals S.

Frequently asked questions

What percentage of Vir Biotechnology is owned by insiders or institutions?
Currently 11.903% of Vir Biotechnology shares are held by insiders and 75.277% by institutions. How many people work for Vir Biotechnology?
Latest data suggests 587 work at Vir Biotechnology. When does the fiscal year end for Vir Biotechnology?
Vir Biotechnology's fiscal year ends in December. Where is Vir Biotechnology based?
Vir Biotechnology's address is: 1800 Owens Street, San Francisco, CA, United States, 94158 What is Vir Biotechnology's ISIN number?
Vir Biotechnology's international securities identification number is: US92764N1028 What is Vir Biotechnology's CUSIP number?
Vir Biotechnology's Committee on Uniform Securities Identification Procedures number is: 92764N102